Posted on Jun 2, 2023
Addiction drug maker will pay more than $102 million fine for stifling competition
263
13
4
3
3
0
https://www.npr.org/2023/06/02/ [login to see] /suboxone-invidior-addiction-drug
The maker of an important addiction treatment medication has agreed to pay $102 million dollars to settle claims it stifled competition. Indivior makes Suboxone, which reduces drug cravings in people with opioid use disorder.
The Virginia-based Indivior introduced Suboxone in 2002 and then, according to state attorneys general, used "monopolistic" strategies to keep generic versions of the opioid-treatment medication off the market.
New York Attorney General Letitia James released a statement saying Indivior "selfishly maneuvered to keep less expensive versions of a life-saving drug out of the hands of millions of Americans" as the opioid crisis grew.
States sued the company in 2016. This settlement with 41 states and the District of Columbia ends that legal fight.
In a statement, Indivior admitted no wrongdoing and said this deal allows the company to focus on patient care.
The maker of an important addiction treatment medication has agreed to pay $102 million dollars to settle claims it stifled competition. Indivior makes Suboxone, which reduces drug cravings in people with opioid use disorder.
The Virginia-based Indivior introduced Suboxone in 2002 and then, according to state attorneys general, used "monopolistic" strategies to keep generic versions of the opioid-treatment medication off the market.
New York Attorney General Letitia James released a statement saying Indivior "selfishly maneuvered to keep less expensive versions of a life-saving drug out of the hands of millions of Americans" as the opioid crisis grew.
States sued the company in 2016. This settlement with 41 states and the District of Columbia ends that legal fight.
In a statement, Indivior admitted no wrongdoing and said this deal allows the company to focus on patient care.
Addiction drug maker will pay more than $102 million fine for stifling competition
Posted from npr.orgPosted in these groups: 
Drugs
Pharmaceuticals
Drugs Pharmaceuticals
Posted 11 mo ago
Responses: 3
4
4
0
Good parents, good upbringing doesn’t make a person immune to addiction. This company should be held responsible for monopolizing the market when cheaper effective drugs could have saved lives. PO1 William "Chip" Nagel
(4)
(0)
Lt Col Scott Shuttleworth
Parent Ms can only do so much. People have to make up their own minds and find their own way eventually. All we can do is our best and leave the rest up to God and pray.
(2)
(0)
2
2
0
PO1 William "Chip" Nagel
"The settlement deal with Indivior, which makes an addiction treatment medication called Suboxone, ends a legal battle with 41 states and the District of Columbia. Spencer Platt / Getty Images The maker of an important addiction treatment medication has agreed to pay $102 million dollars to settle claims it stifled competition."
"The settlement deal with Indivior, which makes an addiction treatment medication called Suboxone, ends a legal battle with 41 states and the District of Columbia. Spencer Platt / Getty Images The maker of an important addiction treatment medication has agreed to pay $102 million dollars to settle claims it stifled competition."
(2)
(0)
2
2
0
PO1 William "Chip" Nagel good day Brother William, always informational and of the most interesting. Thanks for sharing, have a blessed day!
(2)
(0)
Read This Next
Continue with Facebook 
Continue with Google